← Back to Search

Behavioural Intervention

Blood flow restriction group for Ruptured Achilles Tendon

N/A
Recruiting
Research Sponsored by The Methodist Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Receiving PARS or open repair
Achilles Rupture confirmed by MRI or Thompson Test
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-op, 4 weeks post op, 8 weeks post op, 16 weeks post-op
Awards & highlights

Study Summary

This trial aims to see if using blood flow restriction therapy after surgery for an Achilles tendon rupture can reduce muscle loss in the calf, improve recovery, and shorten the time it takes for athletes to return to

Who is the study for?
This trial is for individuals who have recently undergone surgery to repair a ruptured Achilles tendon. Specific eligibility criteria are not provided, but typically participants would need to be in stable health post-surgery and able to commit to the rehabilitation program.Check my eligibility
What is being tested?
The study is testing whether using blood flow restriction therapy alongside physical therapy after an Achilles tendon rupture surgery can reduce muscle loss, improve patient outcomes, and shorten the time it takes for athletes to return to their sport.See study design
What are the potential side effects?
Potential side effects of blood flow restriction therapy may include discomfort or bruising at the site of application, temporary numbness or tingling, and fatigue during exercise. Physical therapy might cause muscle soreness or strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am undergoing or scheduled for PARS or open repair surgery.
Select...
My Achilles tendon is confirmed torn by an MRI or a physical test.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-op, 4 weeks post op, 8 weeks post op, 16 weeks post-op
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-op, 4 weeks post op, 8 weeks post op, 16 weeks post-op for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Bone density preservation
Change in range of motion
Change in single heel raise repetitions
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Standard of Care (control) groupExperimental Treatment1 Intervention
The control group will undergo the normal Achilles tendon rupture reconstruction rehab protocol as determined by Drs. Varner and McCulloch.
Group II: Blood flow restriction groupExperimental Treatment2 Interventions
The study group will undergo normal Achilles tendon rupture reconstruction rehab modified by use of a tourniquet for blood flow restriction during selected exercises.

Find a Location

Who is running the clinical trial?

The Methodist Hospital Research InstituteLead Sponsor
274 Previous Clinical Trials
80,516 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of individuals receiving treatment within this specific clinical trial?

"Yes, the details on clinicaltrials.gov highlight that this investigation is presently seeking candidates. The initial posting of this study occurred on November 13th, 2018, with the most recent update noted on February 8th, 2024. Recruitment aims to enroll a total of 19 participants from a single location."

Answered by AI
~4 spots leftby Dec 2025